Cargando…
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer
BACKGROUND: Circulating tumor DNA (ctDNA) offers minimally invasive means to repeatedly interrogate tumor genomes, providing opportunities to monitor clonal dynamics induced by metastasis and therapeutic selective pressures. In metastatic cancers, ctDNA profiling allows for simultaneous analysis of...
Autores principales: | Weber, Zachary T., Collier, Katharine A., Tallman, David, Forman, Juliet, Shukla, Sachet, Asad, Sarah, Rhoades, Justin, Freeman, Samuel, Parsons, Heather A., Williams, Nicole O., Barroso-Sousa, Romualdo, Stover, Elizabeth H., Mahdi, Haider, Cibulskis, Carrie, Lennon, Niall J., Ha, Gavin, Adalsteinsson, Viktor A., Tolaney, Sara M., Stover, Daniel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136103/ https://www.ncbi.nlm.nih.gov/pubmed/34016182 http://dx.doi.org/10.1186/s13073-021-00895-x |
Ejemplares similares
-
Association of 17q22 Amplicon Via Cell-Free DNA With Platinum Chemotherapy Response in Metastatic Triple-Negative Breast Cancer
por: Collier, Katharine A., et al.
Publicado: (2021) -
Clinical Development of New Antibody–Drug Conjugates in Breast Cancer: To Infinity and Beyond
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2021) -
Technological considerations for genome-guided diagnosis and management of cancer
por: Lennon, Niall J., et al.
Publicado: (2016) -
Evidence to date: talazoparib in the treatment of breast cancer
por: Exman, Pedro, et al.
Publicado: (2019) -
Tumor Mutational Burden in Breast Cancer: Current Evidence, Challenges, and Opportunities
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2023)